Global Analysis of Clinical Trials with Probiotics: new article

Categorised in: Posted on Thu 23rd July

An new article co-funded by the IPA, and co-written by the IPA Scientific Committee Chair Arthur C. Ouwehand has been published on the topic of clinical trials with Probiotics.

“Over 1,000 clinical studies with probiotics, registered at and/or the International Clinical Trials Registry Platform (ICTRP) of the World Health Organization, have addressed over 700 different diseases and conditions. The average size of a clinical trial with probiotics (74 participants) is comparable to the overall average of all studies in Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis ssp. lactis BB12 are the probiotic strains studied most. The exact composition of the product which is used, including the dosage, is not always indicated in the registry. The majority of probiotics studies at is registered in the USA or Europe (56%). The data from ICTRP show the rapid expansion of clinical studies with probiotics in Asia, notably Iran and China.”

Read the full article HERE, or download it HERE.